87 related articles for article (PubMed ID: 9122028)
1. p53 expression in hepatocellular carcinoma in Greece. Correlation with epidemiological and histopathological data.
Skopelitou A; Hadjiyannakis M; Alexopoulou V; Kamina S; Krikoni O; Agnantis NJ
Pathol Res Pract; 1996 Nov; 192(11):1100-6. PubMed ID: 9122028
[TBL] [Abstract][Full Text] [Related]
2. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
3. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
Edamoto Y; Hara A; Biernat W; Terracciano L; Cathomas G; Riehle HM; Matsuda M; Fujii H; Scoazec JY; Ohgaki H
Int J Cancer; 2003 Sep; 106(3):334-41. PubMed ID: 12845670
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia.
Cohen C; DeRose PB
Mod Pathol; 1994 Jun; 7(5):536-9. PubMed ID: 7937718
[TBL] [Abstract][Full Text] [Related]
5. C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study.
Nakopoulou L; Stefanaki K; Filaktopoulos D; Giannopoulou I
Histol Histopathol; 1994 Oct; 9(4):677-82. PubMed ID: 7894139
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in young patients: histology, cellular differentiation, HBV infection and oncoprotein p53.
Jaskiewicz K; Banach L; Izycka E
Anticancer Res; 1995; 15(6B):2723-5. PubMed ID: 8669853
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
Omata M; Ashcavai M; Liew CT; Peters RL
Gastroenterology; 1979 Feb; 76(2):279-87. PubMed ID: 215488
[TBL] [Abstract][Full Text] [Related]
8. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of p53 in a large series of patients with hepatocellular carcinoma: a clinicopathological correlation.
Caruso ML; Valentini AM
Anticancer Res; 1999; 19(5B):3853-6. PubMed ID: 10628323
[TBL] [Abstract][Full Text] [Related]
10. The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells.
Trerè D; Fiume L; De Giorgi LB; Di Stefano G; Migaldi M; Derenzini M
Br J Cancer; 1999 Oct; 81(3):404-8. PubMed ID: 10507763
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of cell cycle and apoptotic proteins in human liver pathologies.
Mitselou A; Karapiperides D; Nesseris I; Vougiouklakis T; Agnantis NJ
Anticancer Res; 2010 Nov; 30(11):4493-501. PubMed ID: 21115898
[TBL] [Abstract][Full Text] [Related]
12. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
13. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
Stroescu C; Dragnea A; Ivanov B; Pechianu C; Herlea V; Sgarbura O; Popescu A; Popescu I
J Gastrointestin Liver Dis; 2008 Dec; 17(4):411-7. PubMed ID: 19104702
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
15. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
[TBL] [Abstract][Full Text] [Related]
19. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
20. Liver cell dysplasia in alpha-1-antitrypsin deficiency.
Cohen C; Derose PB
Mod Pathol; 1994 Jan; 7(1):31-6. PubMed ID: 8159650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
